Literature DB >> 15276887

Injection of orexin A into the diagonal band of Broca induces sympathetic and hyperthermic reactions.

M Monda1, An Viggiano, Al Viggiano, F Fuccio, V De Luca.   

Abstract

This experiment tested the effect of an injection of orexin A into the diagonal band of Broca on the sympathetic activity and body temperature. Concentration of glycerol into white fat of lumbar region, firing rates of sympathetic nerves to interscapular brown adipose tissue (IBAT), IBAT and colonic temperatures, and heart rate were monitored in urethane-anesthetized male Sprague-Dawley rats for 30 min before and 150 min after injections of orexin A (0.4 and 0.7 nmol) into the diagonal band of Broca. The same variables were monitored in control rats with an injection of saline. The results show that orexin A increases glycerol concentration, sympathetic firing rate, IBAT and colonic temperatures, and heart rate. The saline injection did not induce any modification. These findings suggest that the diagonal band of Broca is a cerebral structure involved in the induction of the hyperthermia due to orexin A.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15276887     DOI: 10.1016/j.brainres.2004.05.084

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  12 in total

Review 1.  Energy expenditure: role of orexin.

Authors:  Jennifer A Teske; Vijayakumar Mavanji
Journal:  Vitam Horm       Date:  2012       Impact factor: 3.421

2.  Behavioral responses to orexin, orexin receptor gene expression, and spontaneous physical activity contribute to individual sensitivity to obesity.

Authors:  Claudio E Perez-Leighton; Kelsey Boland; Jennifer A Teske; Charles Billington; Catherine M Kotz
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-07-24       Impact factor: 4.310

Review 3.  Neuropeptides controlling energy balance: orexins and neuromedins.

Authors:  Joshua P Nixon; Catherine M Kotz; Colleen M Novak; Charles J Billington; Jennifer A Teske
Journal:  Handb Exp Pharmacol       Date:  2012

4.  Cerebrospinal fluid hypocretin (orexin) levels are elevated by play but are not raised by exercise and its associated heart rate, blood pressure, respiration or body temperature changes.

Authors:  M-F Wu; R Nienhuis; N Maidment; H A Lam; J M Siegel
Journal:  Arch Ital Biol       Date:  2011-11-07       Impact factor: 1.000

5.  Increased heart rate variability but normal resting metabolic rate in hypocretin/orexin-deficient human narcolepsy.

Authors:  Rolf Fronczek; Sebastiaan Overeem; Robert Reijntjes; Gert Jan Lammers; J Gert van Dijk; Hanno Pijl
Journal:  J Clin Sleep Med       Date:  2008-06-15       Impact factor: 4.062

6.  Involvement of the orexin/hypocretin system in the pharmacological effects induced by Δ(9) -tetrahydrocannabinol.

Authors:  África Flores; Marina Julià-Hernández; Rafael Maldonado; Fernando Berrendero
Journal:  Br J Pharmacol       Date:  2016-03-03       Impact factor: 8.739

7.  Elevated body temperature during sleep in orexin knockout mice.

Authors:  Takatoshi Mochizuki; Elizabeth B Klerman; Takeshi Sakurai; Thomas E Scammell
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2006-09       Impact factor: 3.619

Review 8.  The brain and brown fat.

Authors:  Cristina Contreras; Francisco Gonzalez; Johan Fernø; Carlos Diéguez; Kamal Rahmouni; Rubén Nogueiras; Miguel López
Journal:  Ann Med       Date:  2014-06-10       Impact factor: 4.709

Review 9.  Orexin-A controls sympathetic activity and eating behavior.

Authors:  Giovanni Messina; Carmine Dalia; Domenico Tafuri; Vincenzo Monda; Filomena Palmieri; Amelia Dato; Angelo Russo; Saverio De Blasio; Antonietta Messina; Vincenzo De Luca; Sergio Chieffi; Marcellino Monda
Journal:  Front Psychol       Date:  2014-09-08

Review 10.  Traveling from the hypothalamus to the adipose tissue: The thermogenic pathway.

Authors:  Cristina Contreras; Rubén Nogueiras; Carlos Diéguez; Kamal Rahmouni; Miguel López
Journal:  Redox Biol       Date:  2017-04-15       Impact factor: 11.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.